Approval · Notice of Compliance 18556 · 2016
RYTHMODAN: Notice of Compliance 18556
Issued October 4, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18556
- Date
- October 4, 2016
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Remove 150 mg strength from the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RYTHMODAN | Not yet assigned | — |
Medicinal ingredients
- DISOPYRAMIDE 100 MG per CAP